Biochanin-A contributed cholesterol esterase inhibitory activity, these molecular docking analyses could lead to the further development of potent cholesterol esterase inhibitors for the treatment of obesity (Sivashanmugamet al., 2013). The gene discussed is CEL; the disease is obesity due to melanocortin 4 receptor deficiency.